These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13850662)

  • 1. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. II.
    GOLDIN A; VENDITTI JM; KLINE I; MANTEL N
    Cancer Res; 1960 Jun; 20(5)Pt 2():382-469. PubMed ID: 13850662
    [No Abstract]   [Full Text] [Related]  

  • 2. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. 8.
    VENDITTI JM; KLINE I; GOLDIN A
    Cancer Res; 1964 Jul; 24():827-79. PubMed ID: 14204394
    [No Abstract]   [Full Text] [Related]  

  • 3. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. VII.
    VENDIITI JM; SHELDON DR; GOLDIN A
    Cancer Res; 1964 Jan; 24():145-96. PubMed ID: 14106543
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1961 Apr; 11():73-6. PubMed ID: 13780696
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1960 Feb; 6():55-7. PubMed ID: 13841660
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. IV.
    GOLDIN A; VENDITTI JM; KLINE I; MANTEL N
    Cancer Res; 1961 Apr; 21(3)Pt 2():27-92. PubMed ID: 13706527
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1962 Jun; 19():5-11. PubMed ID: 13925303
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. V.
    GOLDIN A; VENDITTI JM; KLINE I
    Cancer Res; 1962 May; (Suppl)():157-220. PubMed ID: 13899778
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of inhibitory effects of terephthalanilide derivatives against several variants of leukemia L1210.
    LAW LW
    Cancer Chemother Rep; 1962 Jun; 19():13-8. PubMed ID: 14462961
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. VI.
    GOLDIN A; VENDITTI JM; KLINE I
    Cancer Res; 1962 Sep; 2():749-835. PubMed ID: 13948731
    [No Abstract]   [Full Text] [Related]  

  • 13. Antileukemic effects of 5-(2-dimethylaminoethoxy)-7-oxo-7H-benzo(c) fluorene, substance VUFB 13 468, on L1210 and La leukemia.
    Pujman V; Cernochová S
    Neoplasma; 1981; 28(6):715-20. PubMed ID: 7339500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HYDROXYUREA. A NEW TYPE OF POTENTIAL ANTITUMOR AGENT.
    STEARNS B; LOSEE KA; BERNSTEIN J
    J Med Chem; 1963 Mar; 6():201. PubMed ID: 14188794
    [No Abstract]   [Full Text] [Related]  

  • 15. EVALUATION OF ANTILEUKEMIC AGENTS IN THE TREATMENT OF DRUG RESISTANT VARIANTS OF LEUKEMIA L1210.
    VENDITTI JM; GOLDIN A
    Cancer Res; 1963 Jul; 23():SUPPL1011-84. PubMed ID: 14051510
    [No Abstract]   [Full Text] [Related]  

  • 16. HYDROXYMETHYLGLYOXAL BISGUANYLHYDRAZONE.
    LOO TL; DION RL; DAVIDSON JD; ADAMSON RH
    J Med Chem; 1963 Nov; 6():819-20. PubMed ID: 14184964
    [No Abstract]   [Full Text] [Related]  

  • 17. POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
    OETTGEN HF; PURPLE JR; COLEY VC; KRAKOFF IH; BURCHENAL JH
    Cancer Res; 1964 May; 24():689-92. PubMed ID: 14188475
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM; SCHRECKER AW; MEAD JA; KLINE I; GOLDIN A
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
    BRADNER WT; BACHMAN S; PINDELL MH
    Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.